Open AccessRandomized Trial of Folic Acid Supplementation and Serum Homocysteine Levels
Author(s) -
David S Wald,
Lucy Bishop,
Nicholas Wald,
Matthew Law,
Enid Hennessy,
Donald G. Weir,
Joe McPartlin,
John M. Scott
Publication year - 2001
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.161.5.695
Subject(s) - homocysteine , dose , placebo , folic acid , medicine , hyperhomocysteinemia , endocrinology , alternative medicine , pathology
Lowering serum homocysteine levels with folic acid is expected to reduce mortality from ischemic heart disease. Homocysteine reduction is known to be maximal at a folic acid dosage of 1 mg/d, but the effect of lower doses (relevant to food fortification) is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom